A recent study suggests that individuals with a genetic predisposition to higher systolic blood pressure and high-density lipoprotein (HDL) cholesterol may have an increased risk of developing Alzheimer’s disease. The research analyzed data from over 39,000 individuals diagnosed with Alzheimer’s and over 401,000 individuals without the disease. The study found that for every standard deviation increase in HDL cholesterol, the risk of Alzheimer’s increased by approximately 10%, while each 10 mm Hg increase in systolic blood pressure raised the risk by 22%. The findings provide insights into potential drug targets and early prevention strategies for Alzheimer’s disease, emphasizing the importance of considering genetic factors alongside modifiable risk factors in assessing an individual’s overall risk of developing memory issues as they age. However, further research is needed to fully understand the underlying mechanisms behind these associations and to develop effective interventions for Alzheimer’s disease.
Click the image below for full article.